The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis

Frontiers in Immunology

Volumn 5, Issue JUL, 2014, Pages

  Huygen, Kris ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Antigen 85; Immunodominance; Mycolyl transferase; Promiscuous epitopes; Th1 helper T cell

Indexed keywords

EID: 84905640078     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00321     Document Type: Review

References (47)

1. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science (1997) 276:1420-2. doi: 10.1126/science.276.5317.1420
2. Naito M, Ohara N, Matsumoto S, Yamada T. The novel fibronectin-binding motif and key residues of mycobacteria. J Biol Chem (1998) 273:2905-9. doi:10.1074/jbc.273.5.2905
3. Kuo CJ, Ptak CP, Hsieh CL, Akey BL, Chang YF. Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex. J Biol Chem (2013) 288:3886-96. doi:10.1074/jbc.M112.415679
4. Content J, de La Cuvellerie A, De Wit L, Vincent-Levy-Frebault V, Ooms J, De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for Antigen 85-C of M. tuberculosis. Infect Immun (1991) 59:3205-12.
5. Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev (1992) 56:648-61.
6. Warrier T, Tropis M, Werngren J, Diehl A, Gengenbacher M, Schlegel B, et al. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis. Antimicrob Agents Chemother (2012) 56:1735-43. doi:10.1128/AAC.05742-11
7. Lozes E, Denis O, Drowart A, Jurion F, Palfliet K, Vanonckelen A, et al. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-group. Scand J Immunol (1997) 46:16-26. doi:10.1046/j.1365-3083.1997.d01-99.x
8. Brennan MJ, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo A, et al. Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Tuberculosis (Edinb) (2012) 30:2811-23. doi:10.1016/j.vaccine.2012.02.036
9. Brennan MJ, Thole J. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis (Edinb) (2013) 92:S6-13. doi:10.1016/S1472-9792(12)70005-7
10. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A (2000) 97:13853-8. doi:10.1073/pnas.250480397
11. Lee BY, Horwitz MA. T cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infect Immun (1999) 67:2665-70.
12. Huygen K, Lozes E, Gilles B, Drowart A, Palfliet K, Jurion F, et al. Mapping of Th1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect Immun (1994) 62:363-70.
13. D'Souza S, Rosseels V, Romano M, Tanghe A, Denis O, Jurion F, et al. Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B and Ag85C from M. tuberculosis. Infect Immun (2003) 71:483-93. doi:10.1128/IAI.71.1.483-493.2003
14. Yanagisawa S, Koike M, Kariyone A, Nagai S, Takatsu K. Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis. Int Immunol (1997) 9:227-37. doi:10.1093/intimm/9.2.227
15. Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, Nakada M, et al. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol (2004) 16:1691-9. doi:10.1093/intimm/dxh170
16. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med (1996) 2:893-8. doi:10.1038/nm0896-893
17. Lozes E, Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, et al. Immunogenicity and efficacy of tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine (1997) 15:830-3. doi:10.1016/S0264-410X(96)00274-5
18. Denis O, Tanghe A, Palfliet K, Jurion F, Van den Berg TP, Vanonckelen A, et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 66:1527-33.
19. Feller DC, de La Cruz VF. Identifying antigenic T-cell sites. Nature (1991) 349:720-1. doi:10.1038/349720a0
20. McShane H, Behboudi S, Goonetilleke N, Brookes R, Hill AVS. Protective immunity against M. tuberculosis induced by dendritic cells pulsed with both CD8+ and CD4+ T cell epitopes from Antigen 85A. Infect Immun (2002) 70:1623-6. doi:10.1128/IAI.70.3.1623-1626.2002
21. Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, et al. Single mucosal, but not parenteral immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol (2004) 173:6357-65. doi:10.4049/jimmunol.173.10.6357
22. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol (1988) 27:187-94. doi:10.1111/j.1365-3083.1988.tb02338.x
23. Launois P, Deleys R, N'Diaye Niang M, Drowart A, Andrien M, Dierckx P, et al. T cell epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun (1994) 62:3679-87.
24. Mustafa AS, Shaban FA, Abal AT, Al-Attiyah R, Wiker HG, Lundin K, et al. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4+ T-cell lines. Infect Immun (2000) 68:3933-40. doi:10.1128/IAI.68.7.3933-3940.2000
25. Valle MT, Megiovanni AM, Merlo A, Li Pira G, Bottone L, Angelini G, et al. Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85. Clin Exp Immunol (2001) 123:226-32. doi:10.1046/j.1365-2249.2001.01450.x
26. Silver RF, Wallis RS, Ellner JJ. Mapping of T cell epitopes of the 30-kDa a antigen of Mycobacterium bovis strain Bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals. J Immunol (1995) 154:4665-74.
27. Geluk A, Taneja V, van Meijgaarden KE, Zanelli E, Abou-Zeid C, Thole JE, et al. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci U S A (1998) 95:10797-802. doi:10.1073/pnas.95.18.10797
28. Lindestam Arlehamn CS, Gerasimova A, Mele F, Henderson R, Swann J, Greenbaum JA, et al. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog (2013) 9:e1003130. doi:10.1371/journal.ppat.1003130
29. Klein MR, Smith SM, Hammond AS, Ogg GS, King AS, Vekemans J, et al. HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. J Infect Dis (2001) 183:928-34. doi:10.1086/319267
30. Bartek IL, Rutherford R, Gruppo V, Morton RA, Morris RP, Klein MR, et al. The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb) (2009) 89:310-6. doi:10.1016/j.tube.2009.06.001
31. Weichold FF, Mueller S, Kortsik C, Hitzler WE, Wulf MJ, Hone DM, et al. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun (2007) 8:334-43. doi:10.1038/sj.gene.6364392
32. Roche PW, Peake PW, Billman-Jacobe H, Doran T, Britton WJ. T cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun (1994) 62:5319-26.
33. Finan C, Ota MO, Marchant A, Newport MJ. Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccination in a cohort of gambian infants. PLoS One (2008) 3:e3485. doi:10.1371/journal.pone.0003485
34. Geluk A, van Meijgaarden KE, Franken KLMC, Drijfhout JW, D'Souza S, Necker A, et al. Identification of major epitopes of Mycobacterium tuberculosis Ag85B that are recognized by HLA-A*0201 restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol (2000) 165:6463-71. doi:10.4049/jimmunol.165.11.6463
35. Smith SM, Brooks R, Klein MR, Malin AS, Lukey PT, King AS, et al. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol (2000) 165:7088-95. doi:10.4049/jimmunol.165.12.7088
36. Pönnighaus JM, Fine PEM, Sterne JAC, Wilson RJ, Msosa E, Gruer PJK, et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet (1992) 339:636-9. doi:10.1016/0140-6736(92)90794-4
37. Meister GE, Roberts CGP, Berzofsky JA, DeGroot AS. Two novel T cell epitope predicted algorithm based on MHC-binding motifs: comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine (1995) 13:581-91. doi:10.1016/0264-410X(94)00014-E
38. Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K. Protective efficacy of a DNA vaccine encoding Ag85A from M. bovis BCG against Buruli ulcer. Infect Immun (2001) 69:5403-11. doi:10.1128/IAI.69.9.5403-5411.2001
39. Tanghe A, Danzy JP, Pluschke G, Huygen K. Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting. PLoS Negl Trop Dis (2008) 2:e199. doi:10.1371/journal.pntd.0000199
40. Dheenadhayalan V, Shin KS, Chang CF, Chang CD, Wang SJ, McDonough P, et al. Cloning and characterization of the genes coding for Antigen 85A, 85B and 85C of Mycobacterium avium subsp. paratuberculosis. DNA Seq (2002) 13:287-94. doi:10.1080/1042517021000019269
41. Rosseels V, Marché S, Roupie V, Govaerts M, Godfroid J, Walravens K, et al. Members of the 30- to 32-kDa mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle. Infect Immun (2006) 74:202-12. doi:10.1128/IAI.74.1.202-212.2006
42. Rosseels V, Scanlan V, Vanonckelen A, Jurion F, Palfliet K, Marché S, et al. Development of a plasmid DNA based M. paratuberculosis vaccine encoding immunodominant T cell antigens identified in mycobacterial culture filtrate. Seventh International Colloquium on Paratuberculosis International Association for Paratuberculosis, Madison, WI (2003). p. 108-13.
43. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomized, placebo-controlled phase 2b trial. Lancet (2013) 381:1021-8. doi:10.1016/S0140-6736(13)60177-4
44. Romano M, Huygen K. An update on vaccines for tuberculosis-there is more to it than just waning of BCG efficacy with time. Expert Opinion Biol Ther (2012) 12:1601-10. doi:10.1517/14712598.2012.721768
45. Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, et al. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from M. tuberculosis increases the survival time of M. bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine (2006) 24:3353-64. doi:10.1016/j.vaccine.2005.12.066
46. Bruffaerts N, Romano M, Denis O, Jurion F, Huygen K. Increasing the vaccine potential of live M. bovis BCG by coadministration with plasmid DNA encoding a tuberculosis prototype antigen. Vaccine (2014) 2:181-95. doi:10.3390/vaccines2010181
47. Lin PL, Rodgers M, Smith LR, Bigbee M, Myers A, Bigbee C, et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun (2009) 77:4631-42. doi:10.1128/IAI.00592-09